[{"address1": "7 Times Square", "address2": "Suite 2503", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "646 200 5278", "website": "https://www.sellaslifesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.", "fullTimeEmployees": 15, "companyOfficers": [{"maxAge": 1, "name": "Dr. Angelos M. Stergiou M.D., ScD h.c.", "age": 49, "title": "Founder, President, CEO & Director", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 994385, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Thomas Burns CPA", "age": 40, "title": "Senior VP & CFO", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 620894, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Dragan  Cicic M.D., MBA", "age": 62, "title": "Senior VP & Chief Development Officer", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 659364, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stacy E. Yeung", "title": "VP of Legal Affairs, Head of Compliance & Corporate Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Elnatan", "title": "Senior VP of Regulatory Affairs, CMC & Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 3, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 6, "governanceEpochDate": 1767225600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.77, "open": 4.45, "dayLow": 3.96, "dayHigh": 4.66, "regularMarketPreviousClose": 3.77, "regularMarketOpen": 4.45, "regularMarketDayLow": 3.96, "regularMarketDayHigh": 4.66, "payoutRatio": 0.0, "beta": 2.515, "forwardPE": -13.736697, "volume": 29953722, "regularMarketVolume": 29953722, "averageVolume": 6281391, "averageVolume10days": 14415290, "averageDailyVolume10Day": 14415290, "bid": 1.95, "ask": 2.29, "bidSize": 9, "askSize": 4, "marketCap": 641373760, "fiftyTwoWeekLow": 0.85, "fiftyTwoWeekHigh": 4.66, "allTimeHigh": 718500.0, "allTimeLow": 0.5, "fiftyDayAverage": 1.9898, "twoHundredDayAverage": 1.7425, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 575902720, "profitMargins": 0.0, "floatShares": 141749970, "sharesOutstanding": 142442239, "sharesShort": 40466622, "sharesShortPriorMonth": 31792641, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.2841, "heldPercentInsiders": 0.00262, "heldPercentInstitutions": 0.23189, "shortRatio": 8.67, "shortPercentOfFloat": 0.28620002, "impliedSharesOutstanding": 147442240, "bookValue": 0.365, "priceToBook": 11.917808, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -25942000, "trailingEps": -0.28, "forwardEps": -0.31667, "lastSplitFactor": "1:50", "lastSplitDate": 1573171200, "52WeekChange": 3.1037736, "SandP52WeekChange": 0.14778805, "quoteType": "EQUITY", "currentPrice": 4.35, "targetHighPrice": 7.5, "targetLowPrice": 6.0, "targetMeanPrice": 6.83333, "targetMedianPrice": 7.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 44320000, "totalCashPerShare": 0.311, "totalDebt": 599000, "quickRatio": 7.48, "currentRatio": 8.279, "debtToEquity": 1.313, "returnOnAssets": -0.44897, "returnOnEquity": -0.84334, "freeCashflow": -22079124, "operatingCashflow": -30621000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SLS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "SELLAS Life Sciences Group, Inc", "longName": "SELLAS Life Sciences Group, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1205328600000, "postMarketChangePercent": 1.1494297, "postMarketPrice": 4.4, "postMarketChange": 0.05000019, "regularMarketChange": 0.58, "regularMarketDayRange": "3.96 - 4.66", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 6281391, "fiftyTwoWeekLowChange": 3.5, "fiftyTwoWeekLowChangePercent": 4.117647, "fiftyTwoWeekRange": "0.85 - 4.66", "fiftyTwoWeekHighChange": -0.30999994, "fiftyTwoWeekHighChangePercent": -0.0665236, "fiftyTwoWeekChangePercent": 310.37735, "dividendDate": 1573171200, "earningsTimestampStart": 1762981200, "earningsTimestampEnd": 1762981200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.28, "epsForward": -0.31667, "epsCurrentYear": -0.26, "regularMarketChangePercent": 15.3846, "regularMarketPrice": 4.35, "priceEpsCurrentYear": -16.73077, "fiftyDayAverageChange": 2.3602, "fiftyDayAverageChangePercent": 1.1861494, "twoHundredDayAverageChange": 2.6075, "twoHundredDayAverageChangePercent": 1.4964132, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1767401963, "regularMarketTime": 1767387601, "exchange": "NCM", "messageBoardId": "finmb_262231850", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "displayName": "SELLAS Life Sciences", "trailingPegRatio": null, "__fetch_time": "2026-01-03"}]